Review Article
Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
Table 3
Studies evaluating the effect of anthocyanins on hepatic steatosis and steatohepatitis in vivo.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HFD: high fat diet; IR: insulin resistance; TGs: triglycerides; LXR: liver X receptor; FAS: fatty acid synthase; GAPT1: glycerol 3 phosphate acyl transferase; PPAR: peroxisomes proliferator activated receptor ; chol: cholesterol; FFAs: free fatty acids; CPT-1: carnitine-palmitoyl-transferase-1; HMG-CoA red: 3-hydroxymethyl-3-glutaryl-coenzyme A reductase; p: phospho; AMPK: adenosine monophoshopate protein kinase; Srebp1c: sterol regulated element binding protein 1c; ACC: acetyl-coenzyme A carboxylase; ROS: reactive oxygen species; JNK: c-Jun N-terminal kinase; FOXO1: forkhead box O1. |